Buscar
Oncology Institute Inc
TOIAñadir a la lista de seguimiento
4.860USD
-0.210-4.14%
Cierre 07-31 16:00（ET）Cotizaciones retrasadas 15 min
485.87MCap. mercado
PérdidaP/E TTM
Más Datos de Oncology Institute Inc Compañía
The Oncology Institute, Inc. is a value-based oncology company. The Company manages community-based oncology practices which serve patients at approximately 86 clinic locations across 16 markets and five states throughout the United States. The Company's segment includes patient services, dispensary, and clinical trials & other. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion, radiation, and programs like outpatient blood product transfusions, along with 24/7 patient support. The Company, through TOI Clinical Research, LLC (TCR), provides and manages clinical trial services and research for the benefit of cancer patients. The Company also provides management services to over 14 clinic locations owned by independent oncology practices. The Company and its affiliated providers have contractual relationships with payors serving a variety of patients, including Medicare Advantage (MA), Medicaid, and commercial patients.
Información de Oncology Institute Inc
Símbolo de cotizaciónTOI
Nombre de la empresaOncology Institute Inc
Fecha de salida a bolsaMar 13, 2020
Director ejecutivoVirnich (Daniel)
Número de empleados825
Tipo de seguridadOrdinary Share
Fin del año fiscalMar 13
Dirección18000 Studebaker Rd
CiudadCERRITOS
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal90703
Teléfono15627353226
Sitio Webhttps://theoncologyinstitute.com/
Símbolo de cotizaciónTOI
Fecha de salida a bolsaMar 13, 2020
Director ejecutivoVirnich (Daniel)
Ejecutivos de Oncology Institute Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Daniel Virnich, M.D.
Dr. Daniel Virnich, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
692.92K
-3.33%
Ms. Kristin England
Ms. Kristin England
Chief Administrative Officer
Chief Administrative Officer
153.78K
+36.25%
Dr. Mohit Kaushal
Dr. Mohit Kaushal
Independent Director
Independent Director
116.92K
-147.27%
Mr. Robert Ross Carter
Mr. Robert Ross Carter
Chief Financial Officer, Principal Accounting Officer
Chief Financial Officer, Principal Accounting Officer
49.68K
-3.23%
Dr. Yale Podnos
Dr. Yale Podnos
Chief Medical Officer
Chief Medical Officer
43.80K
--
Mr. Brad Hively
Mr. Brad Hively
Independent Vice Chairman of the Board
Independent Vice Chairman of the Board
--
--
Ms. Karen M. Johnson
Ms. Karen M. Johnson
Independent Director
Independent Director
--
--
Ms. Anne Mcgeorge
Ms. Anne Mcgeorge
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Mark L. Pacala
Mr. Mark L. Pacala
Independent Director
Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Daniel Virnich, M.D.
Dr. Daniel Virnich, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
692.92K
-3.33%
Ms. Kristin England
Ms. Kristin England
Chief Administrative Officer
Chief Administrative Officer
153.78K
+36.25%
Dr. Mohit Kaushal
Dr. Mohit Kaushal
Independent Director
Independent Director
116.92K
-147.27%
Mr. Robert Ross Carter
Mr. Robert Ross Carter
Chief Financial Officer, Principal Accounting Officer
Chief Financial Officer, Principal Accounting Officer
49.68K
-3.23%
Dr. Yale Podnos
Dr. Yale Podnos
Chief Medical Officer
Chief Medical Officer
43.80K
--
Mr. Brad Hively
Mr. Brad Hively
Independent Vice Chairman of the Board
Independent Vice Chairman of the Board
--
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Oncology Institute Inc?
Los cinco principales accionistas de Oncology Institute Inc son: Dr. Daniel Virnich, M.D.
¿Cuántas instituciones poseen acciones de Oncology Institute Inc (TOI)?
A fecha de 2026Q1, 204 instituciones poseen acciones de Oncology Institute Inc, con un valor de mercado combinado de aproximadamente 47.47M, lo que representa el 47.57% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -10136464.00.
¿Cuál es la mayor fuente de ganancias de Oncology Institute Inc?
El 2026Q1, el segmento empresarial Dispensary revenue generó la ganancia más alta para Oncology Institute Inc, ascendiendo a 269.18M y representando el 53.54% de la ganancia total.